A breakthrough in the world of medicine – the first antibiotic using artificial intelligence technology.
2 mins read

A breakthrough in the world of medicine – the first antibiotic using artificial intelligence technology.

Artificial intelligence continues to amaze us in all fields. The latest was its innovation in creating a new antibiotic that eliminates resilient bacteria. So, how did this happen?

A recent study published in the journal “Nature Chemical Biology” revealed the development of a new antibiotic using artificial intelligence technology, capable of eradicating lethal bacterial infections that are resistant to drugs.

The results of this study unveiled a new antibiotic called “Abaucin” that can kill a type of resilient bacteria known as “Acinetobacter baumannii,” a dangerous type of antibiotic-resistant bacteria that can cause infections in wounds and pneumonia, and is usually found in hospitals.

The researchers explained that artificial intelligence was utilized after being trained to evaluate the effectiveness of compounds in inhibiting bacterial growth. Data on 6680 new compounds were then introduced. The artificial intelligence program managed to exclude thousands of compounds and choose a limited number with presumed effectiveness. What’s astonishing is that artificial intelligence took less than two hours to select these compounds, a very short time compared to what researchers would normally require for this process.

Afterward, the researchers selected 240 compounds from what artificial intelligence had chosen for practical testing. The results showed the effectiveness of 9 of them, with “Abaucin” being the most effective and powerful in eliminating Acinetobacter baumannii bacteria in wounds when tested on mice infected with it.

In addition to these promising results, it was noted that the antibiotic created by artificial intelligence managed to eliminate these lethal bacteria without affecting beneficial bacteria in the body, unlike other antibiotics. This indicates that the precision of “Abaucin” might prevent the development of resistance against it and could have fewer side effects.

The researchers in this study pointed out that the next step is to start testing the “Abaucin” antibiotic on a wider scale, as well as conducting clinical trials. It is expected that the drug will be available to patients by 2030.

This innovation is a step that could revolutionize the world of medicine and science, and it may help in discovering other antibiotics that can eliminate resistant bacteria and save many lives.

Leave a Reply

Your email address will not be published. Required fields are marked *